217 related articles for article (PubMed ID: 20208001)
21. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
22. Protecting the initial site of viral entry: an alternative HIV vaccine target.
Lopalco L; Bomsel M
Expert Rev Vaccines; 2011 Sep; 10(9):1253-6. PubMed ID: 21919613
[No Abstract] [Full Text] [Related]
23. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
24. T-cell cytokines affect mucosal immunoglobulin A transport.
Amin PB; Diebel LN; Liberati DM
Am J Surg; 2007 Jul; 194(1):128-33. PubMed ID: 17560924
[TBL] [Abstract][Full Text] [Related]
25. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
[TBL] [Abstract][Full Text] [Related]
26. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
Mohan T; Verma P; Rao DN
Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
[TBL] [Abstract][Full Text] [Related]
27. The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner.
Tudor D; Bomsel M
AIDS; 2011 Mar; 25(6):751-9. PubMed ID: 21330910
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.
Mantis NJ; Palaia J; Hessell AJ; Mehta S; Zhu Z; Corthésy B; Neutra MR; Burton DR; Janoff EN
J Immunol; 2007 Sep; 179(5):3144-52. PubMed ID: 17709529
[TBL] [Abstract][Full Text] [Related]
29. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
[TBL] [Abstract][Full Text] [Related]
30. Complement Receptor 3 Mediates HIV-1 Transcytosis across an Intact Cervical Epithelial Cell Barrier: New Insight into HIV Transmission in Women.
Day CJ; Hardison RL; Spillings BL; Poole J; Jurcisek JA; Mak J; Jennings MP; Edwards JL
mBio; 2022 Feb; 13(1):e0217721. PubMed ID: 35012346
[TBL] [Abstract][Full Text] [Related]
31. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
Sánchez-Martínez S; Lorizate M; Hermann K; Kunert R; Basañez G; Nieva JL
FEBS Lett; 2006 Apr; 580(9):2395-99. PubMed ID: 16616522
[TBL] [Abstract][Full Text] [Related]
32. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S
Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623
[TBL] [Abstract][Full Text] [Related]
33. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y
J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478
[TBL] [Abstract][Full Text] [Related]
34. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
35. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
36. Genital immunology and HIV susceptibility in young women.
Yi TJ; Shannon B; Prodger J; McKinnon L; Kaul R
Am J Reprod Immunol; 2013 Feb; 69 Suppl 1():74-9. PubMed ID: 23157424
[TBL] [Abstract][Full Text] [Related]
37. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
Neurath AR; Strick N; Lin K; Jiang S
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):687-96. PubMed ID: 7576928
[TBL] [Abstract][Full Text] [Related]
38. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells.
Gupta S; Gach JS; Becerra JC; Phan TB; Pudney J; Moldoveanu Z; Joseph SB; Landucci G; Supnet MJ; Ping LH; Corti D; Moldt B; Hel Z; Lanzavecchia A; Ruprecht RM; Burton DR; Mestecky J; Anderson DJ; Forthal DN
PLoS Pathog; 2013; 9(11):e1003776. PubMed ID: 24278022
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells.
Wright A; Yan H; Lamm ME; Huang YT
Virology; 2006 Dec 5-20; 356(1-2):165-70. PubMed ID: 16956641
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus transcytosis through polarized oral epithelial cells.
Tugizov SM; Herrera R; Palefsky JM
J Virol; 2013 Jul; 87(14):8179-94. PubMed ID: 23698302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
